【5月23日,恒瑞医药在港交所主板正式挂牌上市,迈入“A+H”双平台时代】恒瑞医药此次发行价每股44.05港元,为发行区间上限定价。其IPO是近五年港股医药板块最大IPO,也是2025年度第二大港股IPO。港股上市4个多月,获国际热烈响应,基石投资者有GIC、景顺等知名机构。开盘高开,开盘价57港元/股,较发行价上涨29.4%。恒瑞医药创立于1970年,2000年在上交所上市。55年来,业务覆盖多...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.